Hiroshi Kiyonari Selected Research

Hiroshi Kiyonari Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 12/2008
5	Obesity 12/2021 - 11/2015
5	Inflammation (Inflammations) 01/2019 - 10/2010
3	Type 2 Diabetes Mellitus (MODY) 07/2022 - 10/2013
3	Hypertrophy 01/2022 - 03/2017
3	Infections 11/2019 - 11/2015
3	Heart Failure 01/2019 - 01/2018
3	Cardiomegaly (Heart Hypertrophy) 01/2019 - 03/2017
3	Insulin Resistance 01/2019 - 03/2008
2	Lymphoma (Lymphomas) 01/2022 - 02/2014
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2022 - 02/2014
2	Body Weight (Weight, Body) 12/2021 - 11/2016
2	Glioma (Gliomas) 01/2019 - 08/2009
2	Non-alcoholic Fatty Liver Disease 01/2019 - 11/2015
2	Hypertension (High Blood Pressure) 01/2018 - 01/2018
2	Carcinoma (Carcinomatosis) 01/2018 - 11/2017
2	Hypersensitivity (Allergy) 11/2015 - 10/2010
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2013 - 10/2010
2	Carcinogenesis 03/2013 - 08/2009
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2022
1	Proteinuria 01/2022
1	Metaplasia 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	B-Cell Leukemia (Leukemia, B Cell) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2021
1	Neurodevelopmental Disorders 01/2021
1	Hydrocephalus (Hydrocephaly) 01/2021
1	Anaphylaxis (Anaphylactic Shock) 12/2020
1	Schizophrenia (Dementia Praecox) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Tremor (Tremors) 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Dermatitis 01/2019
1	Demyelinating Diseases (Demyelinating Disease) 01/2019
1	Allergic Rhinitis 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Cicatrix (Scar) 01/2019
1	Deafness (Deaf Mutism) 01/2019
1	Movement Disorders (Movement Disorder) 01/2019
1	Sepsis (Septicemia) 01/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Sleep Wake Disorders 01/2018
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2018
1	Seizures (Absence Seizure) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Stroke (Strokes) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Septic Shock (Toxic Shock Syndrome) 01/2018

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2008
6	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 03/2008
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2019
3	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2015
2	CalciumIBA 07/2022 - 11/2015
2	ClaudinsIBA 10/2021 - 10/2015
2	Actins (F Actin)IBA 01/2019 - 11/2013
2	LipopolysaccharidesIBA 01/2018 - 03/2015
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2018 - 03/2017
2	Phosphotransferases (Kinase)IBA 11/2017 - 09/2015
2	LigandsIBA 01/2017 - 07/2010
2	Messenger RNA (mRNA)IBA 11/2015 - 02/2008
2	Protein Kinases (Protein Kinase)IBA 09/2015 - 01/2009
2	Tumor Viral Antigens (Large T Antigen)IBA 08/2009 - 03/2008
1	EnzymesIBA 07/2022
1	Uncoupling Protein 2IBA 07/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 07/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022
1	NestinIBA 01/2022
1	spasmolytic polypeptideIBA 01/2022
1	Proteoglycans (Proteoglycan)IBA 01/2021
1	Immunoglobulin E (IgE)IBA 12/2020
1	GTP Phosphohydrolases (GTPases)IBA 12/2020
1	Pathogen-Associated Molecular Pattern MoleculesIBA 11/2019
1	sharpinIBA 01/2019
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2019
1	indium-bleomycinIBA 01/2019
1	fibroblast growth factor 21IBA 01/2019
1	CuprizoneIBA 01/2019
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2019
1	GANT 61IBA 01/2019
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Kruppel-Like Factor 4IBA 01/2019
1	artenimol (dihydroartemisinin)IBA 01/2019
1	Salivary CystatinsIBA 01/2019
1	Cysteine Proteinase InhibitorsIBA 01/2019
1	ADP-Ribosylation Factors (ADP-Ribosylation Factor)IBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	LipidsIBA 01/2018
1	Peptide Elongation Factors (Elongation Factor)IBA 01/2018
1	Cholinergic ReceptorsIBA 01/2018
1	Fatty Acid ElongasesIBA 01/2018

Therapy/Procedure

4	Therapeutics 01/2021 - 12/2016
1	Transplantation 01/2020
1	Transjugular Intrahepatic Portasystemic Shunt 01/2018
1	Intraperitoneal Injections 01/2018